Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
J Nat Prod ; 79(1): 2-12, 2016 Jan 22.
Article in English | MEDLINE | ID: mdl-26731300

ABSTRACT

A known (1) and a structurally related new natural product (2), both belonging to the amorfrutin benzoic acid class, were isolated from the roots of Glycyrrhiza foetida. Compound 1 (amorfrutin B) is an efficient agonist of the nuclear peroxisome proliferator activated receptor (PPAR) gamma and of other PPAR subtypes. Compound 2 (amorfrutin C) showed comparably lower PPAR activation potential. Amorfrutin C exhibited striking antiproliferative effects for human colorectal cancer cells (HT-29 and T84), prostate cancer (PC-3), and breast cancer (MCF7) cells (IC50 values ranging from 8 to 16 µM in these cancer cell lines). Notably, amorfrutin C (2) showed less potent antiproliferative effects in primary colon cells. For HT-29 cells, compound 2 induced G0/G1 cell cycle arrest and modulated protein expression of key cell cycle modulators. Amorfrutin C further induced apoptotic events in HT-29 cells, including caspase activation, DNA fragmentation, PARP cleavage, phosphatidylserine externalization, and formation of reactive oxygen species. Mechanistic studies revealed that 2 disrupts the mitochondrial integrity by depolarization of the mitochondrial membrane (IC50 0.6 µM) and permanent opening of the mitochondrial permeability transition pore, leading to increased mitochondrial oxygen consumption and extracellular acidification. Structure-activity-relationship experiments revealed the carboxylic acid and the hydroxy group residues of 2 as fundamental structural requirements for inducing these apoptotic effects. Synergy analyses demonstrated stimulation of the death receptor signaling pathway. Taken together, amorfrutin C (2) represents a promising lead for the development of anticancer drugs.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Glycyrrhiza/chemistry , Mitochondria/metabolism , Salicylates/isolation & purification , Salicylates/pharmacology , Antineoplastic Agents, Phytogenic/chemistry , Caspases/metabolism , Cell Cycle Checkpoints/drug effects , Cell Proliferation/drug effects , Colonic Neoplasms/metabolism , Drug Screening Assays, Antitumor , Female , G1 Phase Cell Cycle Checkpoints/drug effects , HT29 Cells , Humans , Inhibitory Concentration 50 , Male , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Molecular Structure , Morocco , Peroxisome Proliferator-Activated Receptors/agonists , Plant Roots/chemistry , Reactive Oxygen Species/metabolism , Salicylates/chemistry , Structure-Activity Relationship , bcl-2-Associated X Protein/metabolism
2.
J Nat Prod ; 78(5): 1160-4, 2015 May 22.
Article in English | MEDLINE | ID: mdl-25938459

ABSTRACT

Amorfrutins are isoprenoid-substituted benzoic acid derivatives, which were found in Amorpha fruticosa L. (bastard indigo) and in Glycyrrhiza foetida Desf. (licorice). Recently, amorfrutins were shown to be selective activators of the nuclear receptor PPARγ. Here, we investigated the effects and PPARγ-based mechanisms of reducing inflammation in colon cells by treatment with amorfrutins. In TNF-α-stimulated colon cells amorfrutin A (1) reduced significantly the expression and secretion of several inflammation mediators, in part due to interaction with PPARγ. These results support the hypothesis that amorfrutins may have the potential to treat inflammation disorders such as chronic inflammatory bowel diseases.


Subject(s)
Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Fabaceae/chemistry , PPAR gamma/agonists , Salicylates/isolation & purification , Salicylates/pharmacology , Stilbenes/isolation & purification , Stilbenes/pharmacology , Anti-Inflammatory Agents/chemistry , Glycyrrhiza/metabolism , Molecular Structure , Receptors, Cytoplasmic and Nuclear/metabolism , Salicylates/chemistry , Stilbenes/chemistry , Tumor Necrosis Factor-alpha/pharmacology
3.
PLoS One ; 11(4): e0152398, 2016.
Article in English | MEDLINE | ID: mdl-27050665

ABSTRACT

Massively increasing global incidences of colorectal cancer require efficient treatment and prevention strategies. Here, we report unexpected anticancerogenic effects of hydroethanolic Iberis amara extract (IAE), which is known as a widely used phytomedical product for treating gastrointestinal complaints. IAE significantly inhibited the proliferation of HT-29 and T84 colon carcinoma cells with an inhibitory concentration (IC50) of 6 and 9 µg/ml, respectively, and further generated inhibitory effects in PC-3 prostate and MCF7 breast cancer cells. Inhibition of proliferation in HT-29 cells was associated with a G2/M phase cell cycle arrest including reduced expression of various regulatory marker proteins. Notably, in HT-29 cells IAE further induced apoptosis by intracellular formation of reactive oxygen species (ROS). Consistent with predictions derived from our in vitro experiments, bidaily oral gavage of 50 mg/kg of IAE over 4 weeks resulted in significant inhibition of tumor growth in a mouse HT-29 tumor xenograft model. Taken together, Iberis amara extracts could become useful alternatives for preventing and treating the progression of colon cancer.


Subject(s)
Brassicaceae/chemistry , Colonic Neoplasms/prevention & control , Plant Extracts/pharmacology , Reactive Oxygen Species/metabolism , Animals , Cell Division/drug effects , Cell Line, Tumor , Colonic Neoplasms/pathology , Heterografts , Humans , Mice
4.
Data Brief ; 9: 433-437, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27699197

ABSTRACT

We show here if under physiologically relevant conditions resveratrol (RSV) remains stable or not. We further show under which circumstances various oxidation products of RSV such as ROS can be produced. For example, in addition to the widely known effect of bicarbonate ions, high pH values promote the decay of RSV. Moreover, we analyse the impact of reduction of the oxygen partial pressure on the pH-dependent oxidation of RSV. For further interpretation and discussion of these focused data in a broader context we refer to the article "Hormetic shifting of redox environment by pro-oxidative resveratrol protects cells against stress" (Plauth et al., in press) [1].

5.
Free Radic Biol Med ; 99: 608-622, 2016 10.
Article in English | MEDLINE | ID: mdl-27515816

ABSTRACT

Resveratrol has gained tremendous interest owing to multiple reported health-beneficial effects. However, the underlying key mechanism of action of this natural product remained largely controversial. Here, we demonstrate that under physiologically relevant conditions major biological effects of resveratrol can be attributed to its generation of oxidation products such as reactive oxygen species (ROS). At low nontoxic concentrations (in general <50µM), treatment with resveratrol increased viability in a set of representative cell models, whereas application of quenchers of ROS completely truncated these beneficial effects. Notably, resveratrol treatment led to mild, Nrf2-specific gene expression reprogramming. For example, in primary epidermal keratinocytes derived from human skin this coordinated process resulted in a 1.3-fold increase of endogenously generated glutathione (GSH) and subsequently in a quantitative reduction of the cellular redox environment by 2.61mVmmol GSH per g protein. After induction of oxidative stress by using 0.78% (v/v) ethanol, endogenous generation of ROS was consequently reduced by 24% in resveratrol pre-treated cells. In contrast to the common perception that resveratrol acts mainly as a chemical antioxidant or as a target protein-specific ligand, we propose that the cellular response to resveratrol treatment is essentially based on oxidative triggering. In physiological microenvironments this molecular training can lead to hormetic shifting of cellular defense towards a more reductive state to improve physiological resilience to oxidative stress.


Subject(s)
Fibroblasts/drug effects , Hormesis , Keratinocytes/drug effects , NF-E2-Related Factor 2/genetics , Reactive Oxygen Species/metabolism , Stilbenes/pharmacology , Antioxidants/pharmacology , Ethanol/pharmacology , Fibroblasts/cytology , Gene Expression Regulation , Glutathione/metabolism , HT29 Cells , HeLa Cells , Hep G2 Cells , Humans , Keratinocytes/cytology , NF-E2-Related Factor 2/metabolism , Oxidation-Reduction , Oxidative Stress , Primary Cell Culture , Resveratrol
6.
PLoS One ; 8(11): e80335, 2013.
Article in English | MEDLINE | ID: mdl-24265809

ABSTRACT

Given the significant increases in the incidence of metabolic diseases, efficient strategies for preventing and treating of these common disorders are urgently needed. This includes the development of phytopharmaceutical products or functional foods to prevent or cure metabolic diseases. Plant extracts from edible biomaterial provide a potential resource of structurally diverse molecules that can synergistically interfere with complex disorders. In this study we describe the safe application of ethanolic chamomile (Matricaria recutita) flowers extract (CFE) for the treatment and prevention of type 2 diabetes and associated disorders. We show in vitro that this extract activates in particular nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) and its isotypes. In a cellular context, in human primary adipocytes CFE administration (300 µg/ml) led to specific expression of target genes of PPARγ, whereas in human hepatocytes CFE-induced we detected expression changes of genes that were regulated by PPARα. In vivo treatment of insulin-resistant high-fat diet (HFD)-fed C57BL/6 mice with CFE (200 mg/kg/d) for 6 weeks considerably reduced insulin resistance, glucose intolerance, plasma triacylglycerol, non-esterified fatty acids (NEFA) and LDL/VLDL cholesterol. Co-feeding of lean C57BL/6 mice a HFD with 200 mg/kg/d CFE for 20 weeks showed effective prevention of fatty liver formation and hepatic inflammation, indicating additionally hepatoprotective effects of the extract. Moreover, CFE treatment did not reveal side effects, which have otherwise been associated with strong synthetic PPAR-targeting molecules, such as weight gain, liver disorders, hemodilution or bone cell turnover. Taken together, modulation of PPARs and other factors by chamomile flowers extract has the potential to prevent or treat type 2 diabetes and related disorders.


Subject(s)
Chamomile/chemistry , Flowers/chemistry , Gene Expression Regulation/drug effects , Hypoglycemic Agents/pharmacology , Peroxisome Proliferator-Activated Receptors/genetics , Plant Extracts/pharmacology , Transcription, Genetic/drug effects , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Cell Line , Cells, Cultured , Diet, High-Fat , Dose-Response Relationship, Drug , Dyslipidemias/drug therapy , Dyslipidemias/genetics , Dyslipidemias/metabolism , Fatty Liver/genetics , Fatty Liver/metabolism , Fatty Liver/prevention & control , Gene Knockdown Techniques , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/adverse effects , Insulin Resistance/genetics , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Obese , Non-alcoholic Fatty Liver Disease , PPAR gamma/agonists , PPAR gamma/genetics , PPAR gamma/metabolism , Peroxisome Proliferator-Activated Receptors/agonists , Peroxisome Proliferator-Activated Receptors/metabolism , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL